AA
TMDX icon

ALPS Advisors’s Transmedics TMDX Stock Holding History

ALPS Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Buy
4,031
+20
+0.5% +$1.69K ﹤0.01% 1100
2026
Q1 		$399K Sell
4,011
-3
-0.1% -$391 ﹤0.01% 951
2025
Q4 		$488K Buy
4,014
+34
+0.9% +$4.27K ﹤0.01% 753
2025
Q3 		$447K Buy
+3,980
New +$466K ﹤0.01% 812
2022
Q3 		– Sell
-10,472
Closed -$329K – 1188
2022
Q2 		$329K Buy
+10,472
New +$279K ﹤0.01% 728

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

ALPS Advisors's TMDX Position: Q2 2026 in Review

ALPS Advisors increased its Transmedics (TMDX) stake by 0.5% in Q2 2026, buying an estimated $1.69K and bringing the position to 4,031 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #1100.

ALPS Advisors first reported a position in TMDX in Q2 2022 and has held it in 5 quarters since. The position peaked at $488K in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • ALPS Advisors held 4,031 shares of Transmedics worth $268K as of Q2 2026.
  • ALPS Advisors bought 20 Transmedics shares in Q2 2026, an estimated $1.69K.
  • Transmedics made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #1100 holding.
  • ALPS Advisors first reported a position in Transmedics in Q2 2022 and has held it in 5 quarters since.
  • ALPS Advisors's Transmedics position peaked at $488K in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.